US Corporate Controller

About us

Hansa Biopharma is a fast-growing, commercial-stage biopharmaceutical company, pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with acute or complex immune disorders.

Our broad therapeutic pipeline based on the company’s proprietary IgG-cleaving enzyme technology platform has potential to address serious unmet medical needs in autoimmune diseases, gene therapy, and transplantation.

By empowering our people we move our projects forward with high speed, efficiency and scientific excellence. We strive to attract leading talent from around the world, broaden our network of partners and establish a presence in key markets around the world. There are many opportunities for highly qualified, motivated, and passionate team players to join us on our exciting journey.

Hansa Biopharma was founded in 2007, with the corporate headquarters in Lund, Sweden and has operations in other European countries and in the US. The Company has been listed on the Nasdaq First North Growth Market Stockholm from 2007 to 2015 and on the Nasdaq Stockholm since 2015.

The U.S. Corporate Controller will lead all accounting, financial reporting, and internal control activities for a publicly traded, commercial-stage biotechnology company currently listed on NASDAQ Stockholm, with a potential future listing on NASDAQ. . This role requires deep technical expertise in accounting standards (including working knowledge of IFRS), reporting, and complex financial instruments, as well as the ability to operate in a dynamic, growth-oriented environment.

This role is critical for ensuring smooth financial and HR operations across multiple jurisdictions.

The Controller will play a critical leadership role in supporting the company’s transition to a U.S.

-listed reporting framework, preparing high-quality financial disclosures, and ensuring operational readiness for a commercial launch following regulatory approval of a Biologics License Application (BLA).

This role will be based at our NYC (Manhattan) office when opened and will require the individual to be at a daily commuting distance from NYC on the hybrid schedule.

This job description outlines key responsibilities but does not include all potential tasks or duties.

• Oversee the preparation and filing of all SEC reports, including annual 20-F filings , quarterly filings, and other required filings (e.g., 6-Ks, proxy statements).

• Ensure compliance with accounting standards
  , SEC regulations, and internal accounting policies.

• Lead the drafting and review of financial statements, footnotes, and MD&A disclosures.

• Manage the external audit process and serve as the primary liaison with auditors.

• Prepare monthly, quarterly, and annual financial statements and reports in accordance with U.S. and Swedish reporting standards.

• Collaborate with the global finance team to ensure accurate consolidation of U.S. financial data with the parent company’s accounts.

• Manage budgets, forecasts, and financial planning processes for the U.S. operations.

• Monitor and manage cash flow, bank reconciliations, and ensure timely payments of invoices and other liabilities.

• Ensure compliance with financial regulations, including audits, taxes, and statutory filings.

• Lead accounting for complex transactions, including:

  • Convertible debt instruments and equity-linked securities

  • Debt restructurings and financing transactions

  • Stock-based compensation

  • Revenue recognition in a commercial-stage biotech environment

• Prepare technical accounting memos and support conclusions with authoritative guidance.

• Design,…